TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Orion Pharma A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
33,953
|
28,801
|
28,580 |
Earnings before taxes |
1,473
|
1,321
|
820 |
Total assets |
12,029
|
11,174
|
11,656 |
Current assets |
12,002
|
11,156
|
11,634 |
Current liabilities |
5,094
|
4,389
|
5,212 |
Equity capital |
6,935
|
6,785
|
6,445 |
- share capital |
403
![]() |
403
![]() |
403 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.7%
|
60.7%
|
55.3% |
Turnover per employee |
970
|
823
|
817 |
Profit as a percentage of turnover |
4.3%
|
4.6%
|
2.9% |
Return on assets (ROA) | |||
Current ratio |
235.6%
|
254.2%
|
223.2% |
Return on equity (ROE) |
21.2%
|
19.5%
|
12.7% |
Change turnover |
5,216
|
221
|
-9,459 |
Change turnover % |
18%
|
1%
|
-25% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.